BUY. Structural changes in the making CAPITAL FIRST. Target Price: Rs 920. Key drivers

Size: px
Start display at page:

Download "BUY. Structural changes in the making CAPITAL FIRST. Target Price: Rs 920. Key drivers"

Transcription

1 9 OCT 217 Company Update BUY Target Price: Rs 92 Structural changes in the making We recently interacted with the management of Capital First (CAFL) to get insights of the business and the way forward. The management aims ~25% AUM growth in each of the next two years backed by strong growth in retail financing. CAFL is witnessing strong traction in two wheelers, consumer durables and business loans while it is adopting a softer stance towards loan against property book (share likely to go down to ~35% by FY19 from current ~45%). Added focus on higher-yielding assets and realigning liability mix can improve core NIM by ~5-1 bps by FY19. Expect GNPAs/NNPAs to stay under 2%/1% going forward while C/I ratio is expected to decline to <5% by FY19 due to improvement in top line, increasing productivity, and operating leverage. CAFL is trading at 2.6x FY19E P/ABV. Maintain BUY. CMP : Rs 749 Potential Upside : 23% MARKET DATA No. of Shares : 98 mn Free Float : 64% Market Cap : Rs 73 bn 52-week High / Low : Rs 839 / Rs 465 Avg. Daily vol. (6mth) : 941,286 shares Bloomberg Code : CAFL IB Equity Promoters Holding : 36% FII / DII : 26% / 11% Key highlights Riding the high growth phase The management targets an AUM of ~Rs 3 bn by FY19 and believes focus on retail products like two wheelers, consumer durables, and business loans can help achieve ~25% AUM growth in each of the next two years Core NIM can increase to % by FY19 (1.5% in Q1FY18) with improvement in yields and lower cost of funds (increasing share of non-bank loans; currently at ~5%) Asset quality is likely to stay manageable with GNPAs/NNPAs below 2%/1% going forward while C/I ratio should decline <5% by FY19, which in our view will be a key driver for RoA (~1.6% in FY19) Maintain BUY with a TP of Rs 92 (upside of 23% from CMP): We believe, CAFL s RoE is set to structurally improve from ~1% in FY16 to ~14% in FY19 on improved business (higher share of retail), NIM expansion, operating leverage and healthy asset quality. We value CAFL at 3.2x FY19E P/ABV to arrive at a TP of Rs 92. Financial summary (Consolidated) PAT (Rs mn) 1,662 2,389 3,147 3,915 EPS (Rs) EPS chg Book value (Rs) Adj. BV (Rs) PE (x) P/ABV (x) RoE RoA Net NPA Key drivers Q2 17 Q3 17 Q4 17 Q1 18 AUM (Rs bn) NIM (%, calc.) GNPA C/I ratio GNPA ratio on 9 dpd basis Price performance 14 Sensex Capital First 12 1 Sep-16 Dec-16 Mar-17 Jun-17 Sep-17 1

2 Strong traction in retail AUM to continue CAFL has maintained a robust AUM growth over the past two years despite tenacious rationalization in its wholesale book (share in AUM down from 15% in Q1FY16 to 7% in Q1FY18) At present, mortgage loans/ LAP dominate the AUM with ~45% of the mix. Given the concerns surrounding LAP, the management likes to go slow along with higher levels of diversification bringing its share down to ~35% over the next 6-8 quarters However, being optimistic on retail financing, focus on two wheelers, consumer durables, personal loans and business loans should continue and more than compensate for the decline in LAP portfolio. This in our view will be relatively better off for both margin and asset quality The management continues to guide for ~25% AUM growth and aims for AUM of ~Rs 3 bn by FY19 CAFL is witnessing strong traction in the consumer durables segment due to expansion in newer stores, increase in productivity and better operating leverage The company registered ~.6 mn consumer durable cases in Q1 and is targeting an increased number in coming quarters. This sub-segment is likely to provide a strong margin support which has been on an continuous uptrend over past many quarters (5% in Q1FY14 to 1.5% in Q1FY18) More so, the management sounded optimistic on the growth in affordable housing space. This portfolio is at ~Rs 9.5 bn and the management aims to increase it to Rs 25-3 bn over the next 2-3 years. Increasing share of long tenure portfolio will help in better AUM growth Management aims ~25% AUM growth and targets an AUM of ~Rs 3 bn by FY19 AUM growth is likely to remain strong (Rs bn) AUM 1 YoY Growth (RHS) Existing levers can drive further margin expansion Change in product mix towards higher-yielding products like two wheelers (yield: 22-23%), consumer durables (yield: 27-28%), personal loans (yield: 26-27%) and business loans (yield: 18-19%) have driven rapid expansion in yields over the past couple of years Moreover, changing borrowing mix in favor of market borrowings has driven the cost of funds lower 2

3 The management intends to bring the share of bank borrowings down to ~3-35% over the next 18 months from ~5% at present, which will further bring the cost of funds down Also, CAFL has unutilized sanction lines worth ~Rs 15.5 bn from IFC and ADB that may cost at par/below the market rates, which in our view will bring granularity to its liability franchise and higher credibility The management believes that core NIM can further increase to % from 1.5% in Q1FY18 while including fees, NIM can increase by another 1-1.5% by FY19 In our view, the management s guidance of improvement in NIM is reasonable given that CAFL has ample scope to further increase its exposure to higher yielding loans and can realign liability mix to lower its cost of funds further Core NIM can further increase to % Margin expansion story should continue NIM (RHS) Yields Cost of Funds Asset quality well under control In Q1FY18, CAFL s GNPAs increased by 77 bps QoQ to 1.7% on transitioning to 9 dpd. However, on a like to like basis it increased by mere 7 bps The management believes that given their strong underwriting standards, GNPAs/NNPAs is likely be maintained under 2%/1% going forward To maintain its asset quality, CAFL is not aggressively chasing growth in the LAP segment. More so, it is avoiding very high ticket cases and will like to maintain the average ticket size in the segment at Rs 1 mn GNPAs/NNPAs are likely be maintained under 2%/1% going forward 3

4 GNPAs are likely to stay under manageable levels GNPA NNPA PCR (RHS) 9 dpd (Bps) Expect some improvement in C/I ratio CAFL s Cost/Income (C/I) ratio stood at ~51% in FY17. Despite no massive branch expansion plan in FY18, the ratio is unlikely to wane significantly given the distribution costs attached to the business and increasing share of retail advances CAFL has acquired a small equity stake (invested ~USD 5.5 mn) in Satin Creditcare (MFI) to leverage on its distribution network and not add a lot of physical branches on its own network. This will help in curtailing costs further and expand presence in the bottom of the pyramid However, improvement in top line, increasing productivity and operating leverage is expected to bring C/I ration down to ~5%/~48-49% in FY18/FY19 C/I ratio expected to decline to ~5%/ ~48-49% in FY18/FY19 C/I ratio expected to wane marginally going forward Cost To Income (RHS) Net Income Growth Opex Growth

5 Financial summary (Consolidated) Profit & loss (Rs mn) Interest earned 16,678 23,888 29,118 35,863 Interest expended (8,972) (11,6) (13,718) (16,389) Net interest income 7,75 12,282 15,399 19,474 Non interest income 2,21 4,121 5,24 5,939 Net income 9,916 16,43 2,3 25,413 Operating expenses (5,41) (8,31) (1,188) (12,89) Staff expenses (1,768) (2,394) (3,116) (3,733) Other operating expenses (3,273) (5,916) (7,72) (8,356) Operating profit 4,874 8,93 1,415 13,323 Provisions & contingencies (2,364) (4,53) (5,718) (7,4) Pre-tax profit 2,51 3,564 4,697 5,844 Tax expense (848) (1,174) (1,55) (1,929) Profit after tax 1,662 2,389 3,147 3,915 Extraordinary item Minority interest/associates Adj. PAT 1,662 2,389 3,147 3,915 Balance sheet (Rs mn) Total assets 145, , , ,442 Cash & Balances with RBI 11,127 15,936 21,514 27,968 Investments 1,836 2,587 3,492 4,539 Advances 126, , , ,715 Fixed assets Other assets 4,884 5,31 5,932 6,651 Total liabilities 145, , , ,443 Equity capital Preference capital Reserves & surplus 16,123 22,64 24,892 28,466 Networth 17,35 23,38 25,867 29,44 Borrowings 119, ,81 181,73 228,16 Deposits Other liabilities & prov. 8,666 12,432 14,26 15,987 Key ratios Per share data FDEPS (Rs.) BV (Rs.) Adj. BV (Rs.) DPS (Rs.) Dividend payout Yields & Margins Yield on advances Cost of deposit Net interest margin Asset quality Gross NPAs Net NPAs Credit cost Provisioning coverage Capital Tier-I CAR Efficiency ROA ROE Cost to income CASA Effective tax rate Growth Net interest income Fee income Operating expenses Profit after tax Advances Deposits Total assets Note: Dividend for FY17 will reflect in FY18 due to change in reporting norms 5

6 Disclosures: The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 214 (herein after referred to as the Regulations). 1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH297. ASL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution of various financial products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India s largest private sector bank and has its various subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking, the details in respect of which are available on 2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the Association of Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a corporate agent for insurance business activity. 3. ASL has no material adverse disciplinary history as on the date of publication of this report. 4. I/We, authors (Research team) and the name/s subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect my/our views about the subject issuer(s) or securities. I/We also certify that no part of my/our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL does not have any financial interest in the subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Since associates of ASL are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this report. I/we or my/our relative or ASL or its associates do not have any material conflict of interest. I/we have not served as director, officer or employee in the subject company. Research Team Sr. No Name Designation 1 Hiren Trivedi Research Associate hiren.trivedi@axissecurities.in 2 Kiran Gawle Associate kiran.gawle@axissecurities.in 5. ASL or its associates has not received any compensation from the subject company in the past twelve months. ASL or its Research Analysts has not been engaged in market making activity for the subject company. 6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of its associates may have: i. Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject company of this research report and / or; ii. Managed or co-managed public offering of the securities from the subject company of this research report and / or; iii. Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject company of this research report; ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party in connection with this report Term& Conditions: This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ASL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ASL will not treat recipients as customers by virtue of their receiving this report. 6

7 DEFINITION OF RATINGS Disclaimer: Ratings Expected absolute returns over months BUY More than 1% HOLD Between 1% and -1% SELL Less than -1% Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to the recipient s specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. Certain transactions, including those involving futures, options and other derivatives as well as non-investment grade securities involve substantial risk and are not suitable for all investors. ASL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. Past performance is not necessarily a guide to future performance. Investors are advise necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or investment banker, lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting this document. ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ASL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed, directly or indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is inadvertently sent or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The Company reserves the right to make modifications and alternations to this document as may be required from time to time without any prior notice. The views expressed are those of the analyst(s) and the Company may or may not subscribe to all the views expressed therein. Copyright in this document vests with Axis Securities Limited. Axis Securities Limited, Corporate office: Unit No. 2, Phoenix Market City, 15, LBS Road, Near Kamani Junction, Kurla (west), Mumbai-47, Tel No. 1218/ , Regd. off.- Axis House, 8th Floor, Wadia International Centre, PandurangBudhkarMarg, Worli, Mumbai Compliance Officer: AnandShaha, compliance.officer@axisdirect.in, Tel No: SEBI-Portfolio Manager Reg. No. INP654 7

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights JK 20 NOV 2017 Quarterly Update BUY Target Price: Rs 1,220 White cement steals the show JK Cement s (JKCE) Q2FY18 EBITDA at Rs 2.1 bn (up 30% YoY) was higher than our and consensus estimates, mainly due

More information

HOLD. Buyback of Old Mutual s stake in K-Life KOTAK MAHINDRA BANK. Target Price: Rs 965

HOLD. Buyback of Old Mutual s stake in K-Life KOTAK MAHINDRA BANK. Target Price: Rs 965 4 MAY 17 Flash Note HOLD Target Price: Rs 965 Buyback of Old Mutual s stake in K-Life Event: Kotak Mahindra Bank (KMB) released a statement today announcing plans to buy back Old Mutual s (foreign partner)

More information

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E. At inflection point Q2FY18 adjusted PAT grew 12% YoY at Rs 27 bn (vs. our estimate Rs 26 bn) in tandem with 17% YoY rise in regulated equity. Core RoE is still healthy at 20.2% though it contracted ~174

More information

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights AMBUJA S 4 MAY 2017 Quarterly Update HOLD Target Price: Rs 232 Margins to improve from Q2 Q1CY17standalone EBITDA at Rs 4.0 bn was in line withconsensus estimate.volume was up 3% YoY to 6 mnt. Realization

More information

He is BTech from IIT Bombay ( , Aeronautical Engineering) and MS from Cornell University ( , Mechanical Engineering).

He is BTech from IIT Bombay ( , Aeronautical Engineering) and MS from Cornell University ( , Mechanical Engineering). Stabilizing the Ship; focus shifts to strategy Infosys has appointed Mr. Salil S Parekh as CEO and MD effective January 2, 2018 for a period of 5 years. He would be based out of Bengaluru (India). Also,

More information

Investment Horizon: Though the ideal investment horizon for such ideas remain 6-9 months, our picks may provide some profit-making

Investment Horizon: Though the ideal investment horizon for such ideas remain 6-9 months, our picks may provide some profit-making Pick of the Week 1 Pick of the Week In an ever-changing business environment, some of our investment ideas seem more convincing than others due to better earning visibility and/or attractive valuation.

More information

BUY MULTI COMMODITY EXCHANGE OF INDIA. Strong Q2; All eyes on option volumes. Target Price: Rs 1,280. Concall highlights

BUY MULTI COMMODITY EXCHANGE OF INDIA. Strong Q2; All eyes on option volumes. Target Price: Rs 1,280. Concall highlights 25 OCT 2017 Quarterly Update BUY Target Price: Rs 1,280 Strong Q2; All eyes on option volumes Revenue increased ~5% QoQ to Rs 915 mn due to higher traded value (up ~17% QoQ) led by bullion (up ~17% QoQ)

More information

Hold Target Price: Rs 574

Hold Target Price: Rs 574 03 MAY 2017 Quarterly Update Hold Target Price: Rs 574 Q4FY17: Macro overhang persists SQS India BFSI Ltd delivered a modest performance in Q4FY17, with earnings (PAT) coming in at Rs 4.4 Cr, down 58.8%

More information

BUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E

BUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E Robust quarter with clear growth visibility Dilip Buildcon s (DBL) Q1FY18 sales grew 60% YoY to Rs 16.6 bn, ahead of our estimate of Rs 12.0 bn and consensus of Rs 13.6 bn. EBITDA was up 47% at Rs 3.0

More information

BUY. IIB-BHAFIN merger a done deal INDUSIND BANK. Target Price: Rs 1,920. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E

BUY. IIB-BHAFIN merger a done deal INDUSIND BANK. Target Price: Rs 1,920. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E IIB-BHAFIN merger a done deal The long awaited IIB-BHAFIN merger is finally sailing through with the bank acquiring the MFI in a share swap ratio of ~0.64x, entailing 639 shares of IIB for 1,000 shares

More information

Change EPS. (Rs) FY

Change EPS. (Rs) FY 17 AUG 217 / Quarterly Update BUY Target Price: Rs. 662 : Revenue up 21% Y-o-Y, strong growth in Non-GLE segment GMM Pfaudler Ltd(GMM) in 1QFY18posted revenues of Rs 69 Cr. (up 21% Y-o-Y, down 13% Q-o-Q)

More information

Investment Horizon: Though the ideal investment horizon for such ideas remain 6-9 months, our picks may provide some profit-making

Investment Horizon: Though the ideal investment horizon for such ideas remain 6-9 months, our picks may provide some profit-making Pick of the Week 1 Pick of the Week In an ever-changing business environment, some of our investment ideas seem more convincing than others due to better earning visibility and/or attractive valuation.

More information

BUY. Weak P&L performance, good b/s show POWER FINANCE CORP. Target Price: Rs 135. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

BUY. Weak P&L performance, good b/s show POWER FINANCE CORP. Target Price: Rs 135. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E Weak P&L performance, good b/s show PFC reported a disappointing P&L performance with Q3 PAT at Rs 16 bn (down 17.7% YoY; our est. Rs 18.6 bn), primarily led by sharp decline in NIM (down 35 bps QoQ at

More information

BUY MULTI COMMODITY EXCHANGE OF INDIA. Demonetization,GST uncertainty impact Q4. Target Price: Rs 1,397. Concall highlights

BUY MULTI COMMODITY EXCHANGE OF INDIA. Demonetization,GST uncertainty impact Q4. Target Price: Rs 1,397. Concall highlights 09 MAY 2017 Quarterly Update BUY Target Price: Rs 1,397 Demonetization,GST uncertainty impact Q4 Revenue declined 12% QoQ at Rs 874 mn due to lower traded value (down 10% QoQ). Bullion (~35% of traded

More information

BUY. Q4 hurt by MFI business EQUITAS HOLDINGS. Target Price: Rs 190

BUY. Q4 hurt by MFI business EQUITAS HOLDINGS. Target Price: Rs 190 Q4 hurt by MFI business Q4FY17 was subdued due to moderation in AUM growth, significant decline in margin and further deterioration in headline asset quality. Additionally, higher operating expenses (due

More information

BUY STEEL STRIPS WHEELS LTD. Target Price: Rs Q4FY17: Heavier wheels outperform, strong growth triggers ahead FINANCIAL SUMMARY

BUY STEEL STRIPS WHEELS LTD. Target Price: Rs Q4FY17: Heavier wheels outperform, strong growth triggers ahead FINANCIAL SUMMARY 12 JUNE 2017 Quarterly Update BUY Target Price: Rs 1061 Q4FY17: Heavier wheels outperform, strong growth triggers ahead Steel Strips Wheels Limited s (SSWL) in 4QFY17 posted revenues of Rs 380 Cr. (up

More information

BUY. Outperformance continues GULF OIL LUBRICANTS INDIA. Target Price: Rs 1,000. Hike estimates and TP; maintain BUY

BUY. Outperformance continues GULF OIL LUBRICANTS INDIA. Target Price: Rs 1,000. Hike estimates and TP; maintain BUY Outperformance continues Gulf Oil s core volumes grew 7% YoY in Q1FY18 (vs. 10% normal growth) even as GST-led destocking led to 10-15% volume degrowth for peer lubricant players. Volumes are likely to

More information

HOLD. Performance remains weak COLGATE-PALMOLIVE INDIA. Target Price: Rs 900

HOLD. Performance remains weak COLGATE-PALMOLIVE INDIA. Target Price: Rs 900 HOLD Target Price: Rs 900 Performance remains weak Net sales grew only 3% YoY as volumes declined ~3% due to sustained pressure in wholesale. Toothpaste market share declined 120 bps YoY to 54.1% but toothbrush

More information

BUY. Well poised for strong growth RBL BANK. Target Price: Rs 650. Key highlights. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

BUY. Well poised for strong growth RBL BANK. Target Price: Rs 650. Key highlights. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E 4 APR 218 Visit Note BUY Target Price: Rs 65 Well poised for strong growth We met with the senior management of RBL and came back confident on its outlook and execution capabilities. Growth rates to remain

More information

BUY. GST pressures dealt well HINDUSTAN UNILEVER. Target Price: Rs 1,400. Key drivers (%) FY16 FY17 FY18E FY19E

BUY. GST pressures dealt well HINDUSTAN UNILEVER. Target Price: Rs 1,400. Key drivers (%) FY16 FY17 FY18E FY19E GST pressures dealt well Q2 tops estimates: Net sales, EBITDA and adj. PAT grew 7%, 20% and 19%, vs. consensus expectation of 7%, 14% and 11%. Like to like^ (LTL) domestic consumer revenue grew ~10% on

More information

HOLD. Going aggressive in hair oils DABUR INDIA. Target Price: Rs 325. Key drivers (%) FY17 FY18E FY19E

HOLD. Going aggressive in hair oils DABUR INDIA. Target Price: Rs 325. Key drivers (%) FY17 FY18E FY19E 25 OCT 2017 Company Update HOLD Target Price: Rs 325 Going aggressive in hair oils Dabur India has stepped up its aggression in the Indian hair oils segment. Recent advertisements show Dabur offering its

More information

BUY Target Price: Rs 1,218

BUY Target Price: Rs 1,218 New growth avenues Interaction with Bharat Forge (BFL) top management and tour of its technical centre suggests strong growth opportunities in new areas like defense, aerospace, and auto transmission.

More information

HOLD PVR. Operating matrix healthy; footfalls subdued. Target Price: Rs 1,520. Key highlights

HOLD PVR. Operating matrix healthy; footfalls subdued. Target Price: Rs 1,520. Key highlights Operating matrix healthy; footfalls subdued Q3 was largely in line with expectations. Limited box-office success led to lower footfalls (down 2%) and occupancy (~29% vs. 32% YoY) despite ~7% increase in

More information

BUY. Strong quarter, bright outlook MAHINDRA CIE AUTOMOTIVE. Target Price: Rs 274. Takeaways from concall. Key drivers (%)

BUY. Strong quarter, bright outlook MAHINDRA CIE AUTOMOTIVE. Target Price: Rs 274. Takeaways from concall. Key drivers (%) MAHINDRA CIE MOTIVE Strong quarter, bright outlook Q4CY17 results were 6% ahead of estimates at operational level, as both India and Europe operations continued to deliver on both topline and EBITDA margin

More information

BUY. Quess likely to be spun-off; stay invested THOMAS COOK (INDIA) Target Price: Rs 320

BUY. Quess likely to be spun-off; stay invested THOMAS COOK (INDIA) Target Price: Rs 320 Quess likely to be spun-off; stay invested Thomas Cook s (TCIL) board has approved the proposal of a corporate restructuring exercise that would enable the company to focus on Travelrelated businesses

More information

HOLD. FY18 off to a good start GODREJ PROPERTIES. Target Price: Rs 486. Q4FY17 key highlights

HOLD. FY18 off to a good start GODREJ PROPERTIES. Target Price: Rs 486. Q4FY17 key highlights 09 MAY 2017 Quarterly Update HOLD Target Price: Rs 486 FY18 off to a good start Godrej Properties Ltd (GPL) has booked pre-sales of Rs 9-10 bn in April 2017driven by launch of 3 projects The Trees Origins

More information

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and

More information

BUY. FY17 a blip; gradual recovery ahead APOLLO HOSPITALS ENTERPRISE. Target Price: Rs 1,472

BUY. FY17 a blip; gradual recovery ahead APOLLO HOSPITALS ENTERPRISE. Target Price: Rs 1,472 FY17 a blip; gradual recovery ahead Apollo Hospital s FY17 earnings miss (EBITDA at Rs 7.3 bn vs. our expectation of Rs 7.8 bn) was largely due to lower than expected margin in matured hospitals. Stent

More information

BUY. Multiple margin tailwinds; BUY HINDUSTAN UNILEVER. Target Price: Rs 1,010. Key drivers (%) FY16 FY17E FY18E FY19E

BUY. Multiple margin tailwinds; BUY HINDUSTAN UNILEVER. Target Price: Rs 1,010. Key drivers (%) FY16 FY17E FY18E FY19E Multiple margin tailwinds; BUY After maintaining a neutral call on HUVR for past two years, we upgrade it to BUY on the back of (i) multiple margin tailwinds, (ii) slow but steady improvement in volume

More information

BUY. Shedding non-core assets TATA POWER. Target Price: Rs 136. Financial summary (Consolidated) Key drivers. Price performance

BUY. Shedding non-core assets TATA POWER. Target Price: Rs 136. Financial summary (Consolidated) Key drivers. Price performance Shedding non-core assets Q3 PAT at Rs 6.3 bn beat our estimate of Rs 5.7 bn mainly due to lower-than-expected losses at Mundra UMPP on improving operational metrics. Up-to-mark performance by coal companies

More information

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E RAMCO S BUY Target Price: Rs 435 Efforts on cost cutting paying off Q2 EBITDA at Rs 2.8 bn (up 30% YoY) was ahead of our estimates due to lower-than-expected costs. Average costs (excluding freight) declined

More information

Karnataka Bank. Rating: BUY. Bank - Private. Short Note. Brief Financials

Karnataka Bank. Rating: BUY. Bank - Private. Short Note. Brief Financials Karnataka Bank Bank - Private Date June 11, 2018 CMP (Rs.) 120 Target (Rs.) 163 Potential Upside 37% BSE Sensex 35484 NSE Nifty 10787 Scrip Code Bloomberg KBLIN Reuters KBNK.BO BSE Group A BSE Code 532652

More information

NOW ON APP Research at your finger tips

NOW ON APP Research at your finger tips NOW ON APP Research at your finger tips 15 FEB 2018 Quarterly Update BUY Target Price: Rs 470 ODC project takes breather; to rebound in Q4 Q3 pre-sales declined QoQ to Rs 1 bn (Rs 1.7 bn in Q2) on lower

More information

Punjab National Bank

Punjab National Bank Nov-14 Dec-14 Jan-15 Mar-15 Apr-15 May-15 Jul-15 Aug-15 Sep-15 Nov-15 India Research Banking November 09, 2015 QUARTERLY REVIEW Bloomberg: PNB IN Reuters: PNBK.BO SELL Asset quality improves but recovery

More information

Buy Rating as per Mid Cap 12months investment period

Buy Rating as per Mid Cap 12months investment period Q2FY18 RESULT UPDATE Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 RETAIL EQUITY RESEARCH Dewan Housing Finance Corporation (DHFL) NBFC BSE CODE: 511072 NSE

More information

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone) Feb-15 Jun-15 Oct-15 Feb-16 Jun-16 Oct-16 Feb-17 Jun-17 Oct-17 Feb-18 3QFY2018 Result Update Banking February 15, 2018 ICICI Bank Performance Highlights Particulars (` cr) 3QFY18 2QFY18 % chg (qoq) 3QFY17

More information

BUY CMP (Rs.) 297 Target (Rs.) 385 Potential Upside 30%

BUY CMP (Rs.) 297 Target (Rs.) 385 Potential Upside 30% Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16 May- Jun-16 Jul-16 Aug-16 Aug-16 Sep-16 Oct-16. Volume No.. I Issue No. 95 Dewan Housing Finance Corporation (DHFL) Nov. 4, 2016 BSE Code: 511072 NSE Code: DHFL

More information

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart Apr-16 Sep-16 Feb-17 Jul-17 Dec-17 May-18 Oct-18 Mar-19 Q4FY2019 Result Update Banking Apr 22, 2019 HDFC Bank Operating performance strong; improved NIM Particulars (` cr) Q4FY19 Q3FY19 % chg (qoq) Q4FY18

More information

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials Oct-15 Feb-16 Jun-16 Oct-16 Feb-17 Jun-17 Oct-17 Feb-18 Jun-18 Oct-18 Q2FY2019 Result Update Banking Oct 20, 2018 HDFC Bank Performance Highlights Particulars (` cr) Q2FY19 Q1FY19 % chg (qoq) Q2FY18 %

More information

HDFC Bank. BUY CMP (Rs.) 1,807 Target (Rs.) 2,000 Potential Upside 11%

HDFC Bank. BUY CMP (Rs.) 1,807 Target (Rs.) 2,000 Potential Upside 11% Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17. Volume No.. I Issue No. 147 HDFC Bank Oct. 31, 2017 BSE Code: 500180 NSE Code: HDFCBANK Reuters Code: HDBK.NS

More information

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. GEOJIT BNP PARIBAS Research. CMP Rs259 TARGET Rs284 RETURN 10% 22 nd August 2016

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. GEOJIT BNP PARIBAS Research. CMP Rs259 TARGET Rs284 RETURN 10% 22 nd August 2016 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Q1FY17 RESULT UPDATE GEOJIT BNP PARIBAS Research RETAIL EQUITY RESEARCH State Bank of India (SBI) Banking BSE

More information

DCB Bank (DCB) 208. Healthy fundamentals priced in. Company Update. ICICI Securities Ltd Retail Equity Research. June 13, 2017

DCB Bank (DCB) 208. Healthy fundamentals priced in. Company Update. ICICI Securities Ltd Retail Equity Research. June 13, 2017 Company Update Rating matrix Rating : Hold Target : 200 Target Period : 12 months Potential Upside : -4% What s Changed? Target Changed from 165 to 200 EPS FY18E EPS FY19E Rating Key Financials Crore FY16

More information

Fineotex Chemical Ltd

Fineotex Chemical Ltd Company Update Decent Performance under Macroeconomic Pressure; Business Traction to Continue: Fineotex Chemical recorded decent set of result as consolidated sales grew by 1.1% YoY (largely in line) to

More information

BUY. Recovery ahead; upgrade to BUY BAJAJ AUTO. Target Price: Rs 3,905. Key takeaways from our meeting with the management

BUY. Recovery ahead; upgrade to BUY BAJAJ AUTO. Target Price: Rs 3,905. Key takeaways from our meeting with the management BAJAJ 22 JAN 2018 Company Update BUY Target Price: Rs 3,905 Recovery ahead; upgrade to BUY Bajaj Auto had a tough last 5-6 years due to weakness in exports and domestic 2Ws. Consequently, even after 7%

More information

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone) Jan-16 May-16 Sep-16 Jan-17 May-17 Sep-17 Jan-18 May-18 Sep-18 Jan-19 Q3FY2019 Result Update Banking Jan 22, 2019 HDFC Bank Performance Highlights BUY CMP `2,145 Target Price `2,500 Particulars (` cr)

More information

IndusInd Bank (INDBA) 1717

IndusInd Bank (INDBA) 1717 Event Update Rating matrix Rating : Buy Target : 1920 Target Period : 12 months Potential Upside : 12% What s Changed? Target EPS FY18E EPS FY19E Rating Price chart October 16, 2017 IndusInd Bank (INDBA)

More information

Reliance Housing Finance

Reliance Housing Finance Sep-17 Jun-17 Apr-17 Feb-17 Dec-16 Oct-16 Aug-16 Jun-16 Apr-16 Jan-16 Nov-15 Sep-15 Management Meet Rating matrix (Reliance Housing Finance) Rating Listing 115-120 Target Period Potential Upside Key financials

More information

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. Outlook getting better. CMP Rs278 TARGET Rs310 RETURN 12% 17 th November 2016

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. Outlook getting better. CMP Rs278 TARGET Rs310 RETURN 12% 17 th November 2016 Q2FY17 RESULT UPDATE GEOJIT BNP PARIBAS Research RETAIL EQUITY RESEARCH State Bank of India (SBI) Banking BSE CODE: 500112 NSE CODE: SBIN Bloomberg CODE: SBIN:IN SENSEX: 26,228 BUY Rating as per Large

More information

Margin boost through non-core book

Margin boost through non-core book INDUSTRY NBFCs CMP (as on 26 Apr 2017) Rs 676 Target Price Rs 600 Nifty 9,352 Sensex 30,133 KEY STOCK DATA Bloomberg LICHF IN No. of Shares (mn) 505 MCap (Rs bn) / ($ mn) 341/5,319 6m avg traded value

More information

Union Bank of India (UNIBAN)

Union Bank of India (UNIBAN) Result Update Rating matrix Rating : Hold Target : 22 Target Period : 12 months Potential Upside : 5 % Key Financials crore FY1 NII 4192 6216 714 8312 PPP 3659 435 496 552 PAT 275 282 1915 2439 Valuation

More information

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone) Jul-15 Nov-15 Mar-16 Jul-16 Nov-16 Mar-17 Jul-17 Nov-17 Mar-18 Jul-18 1QFY2019 Result Update Banking July 30, 2018 ICICI Bank Performance Highlights Particulars (` cr) 3QFY18 2QFY18 % chg (qoq) 3QFY17

More information

Financial summary. Year

Financial summary. Year : price: ABV: How does our one year outlook change? We retain our positive outlook on KVB, led by an improving margin profile and cost containment kicking in, while our key thesis - a proven sole banking

More information

Simplex Infrastructures

Simplex Infrastructures May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 Mar-15 Apr-15 May-15 India Research Infrastructure May 27, 2015 QUARTERLY REVIEW Bloomberg: SINF IN Reuters: SINF.BO HOLD Working capital ease to improve

More information

HOLD Rating as per Large Cap 12 month investment period

HOLD Rating as per Large Cap 12 month investment period Q2FY19 RESULT UPDATE Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 RETAIL EQUITY RESEARCH HDFC NBFC BSE CODE: 500010 NSE CODE: HDFC Bloomberg CODE: HDFC:IN SENSEX:

More information

ICICI BANK Ltd. BUY CMP (Rs.) 334 Target (Rs.) 382 Potential Upside 15% Tide set to turn favourably... For private circulation only

ICICI BANK Ltd. BUY CMP (Rs.) 334 Target (Rs.) 382 Potential Upside 15% Tide set to turn favourably... For private circulation only Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Volume No.. III Issue No. 160. ICICI BANK Ltd. Feb. 08, 2018 BSE Code: 532174 NSE Code: ICICIBANK Reuters Code:

More information

Bajaj Finserv (BAFINS) 5443

Bajaj Finserv (BAFINS) 5443 Aug-17 Jun-17 Apr-17 Feb-17 Dec-16 Oct-16 Aug-16 May-16 Mar-16 Jan-16 Nov-15 Sep-15 Company Update Rating matrix Rating Buy Target 6000 Target Period 12 months Potential Upside 10% What s Changed? Target

More information

HDFC Bank Banking BUY RETAIL EQUITY RESEARCH

HDFC Bank Banking BUY RETAIL EQUITY RESEARCH Q4FY17 RESULT UPDATE May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 GEOJIT RESEARCH Feb-17 Mar-17 Apr-17 May-17 RETAIL EQUITY RESEARCH HDFC Bank Banking BSE CODE: 500180 NSE CODE: HDFCBANK

More information

Equitas Holdings. Rating: Target price: ABV: Target CMP. Rating. Rs Rs. 226 BUY

Equitas Holdings. Rating: Target price: ABV: Target CMP. Rating. Rs Rs. 226 BUY : price: ABV: How does our one year outlook change? Remains a idea in the SFB space owing to a well-diversified product profile, prudence in approaching the MFI space marked by the lowest ticket size amongst

More information

Ujjivan Financial Services Ltd.: Q3FY18 Result Update

Ujjivan Financial Services Ltd.: Q3FY18 Result Update Edelweiss Investment Research Ujjivan Financial Services Ltd.: Q3FY18 Result Update Good show; Robust outlook Ujjivan Financial Services Ltd. (UFS) reported a mixed set of numbers in its Q3FY18 financial

More information

BUY. ICICI Bank RETAIL EQUITY RESEARCH. Banking. ddd******* GEOJIT Research. Strong traction in retail segment continues

BUY. ICICI Bank RETAIL EQUITY RESEARCH. Banking. ddd******* GEOJIT Research. Strong traction in retail segment continues Q3FY17 RESULT UPDATE Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 GEOJIT Research Nov-16 Dec-16 Jan-17 Feb-17 RETAIL EQUITY RESEARCH ICICI Bank Ltd Banking BSE CODE:532174 NSE CODE: ICICIBANK

More information

FY17 FY18 FY19E FY20E

FY17 FY18 FY19E FY20E 102015 012016 042016 072016 102016 012017 042017 072017 102017 012018 042018 072018 Q2FY19 Result Update Institutional Research October 25, 2018 Kotak Mahindra Bank Q2FY19 Result Update Strong growth in

More information

State Bank of India (SBI)

State Bank of India (SBI) Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17. Volume No.. II Issue No. 126 State Bank of India (SBI) June 23, 217 BSE Code: 5112 NSE Code: SBIN Reuters Code:

More information

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH COMPANY UPDATE Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 RETAIL EQUITY RESEARCH State Bank of India (SBI) Banking BSE CODE: 500112 NSE CODE: SBIN Bloomberg

More information

FY16 FY17 FY18E FY19E

FY16 FY17 FY18E FY19E 24 JUL 2017 Annual Report Analysis BUY Target Price: Rs 6,025 Annual Report Analysis GSK Consumer s FY17 annual report largely highlights the company s renewed thrust on the core portfolio by making the

More information

ICICI Bank Banking BUY RETAIL EQUITY RESEARCH

ICICI Bank Banking BUY RETAIL EQUITY RESEARCH Q4FY17 RESULT UPDATE May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 RETAIL EQUITY RESEARCH ICICI Bank Banking BSE CODE: 532174 NSE CODE: ICICIBANK Bloomberg

More information

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart 3QFY2017 Result Update HFC January 17, 2017 LIC Housing Finance Performance Highlights Particulars (` cr) 3QFY17 2QFY17 % chg (qoq) 3QFY16 % chg (yoy) NII 915 866 5.7 747 22.6 Pre-prov. profit 811 791

More information

Bajaj Finance (BAJAF) 5498

Bajaj Finance (BAJAF) 5498 Management Meet Note Rating matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials Crore FY12 FY13 FY14 FY15 NII 1,25 1,717 2,215 2,872 PPP 756 1,53 1,349 1,742 PAT

More information

BUY Rating as per Largecap 12months investment period

BUY Rating as per Largecap 12months investment period Q4FY17 RESULT UPDATE May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 RETAIL EQUITY RESEARCH Dewan Housing Finance Corporation (DHFL) NBFC BSE CODE: 511072 NSE

More information

Key estimate revision. Financial summary. Year

Key estimate revision. Financial summary. Year : price: ABV: How does our one year outlook change? While we continue to believe that SUF is a multi-year compounding opportunity in the asset and home financing segments, we take note of the under-performance

More information

Visaka Industries Ltd

Visaka Industries Ltd Company Update Superior Product Mix & New Age Markets to Aid Growth New investments to aid growth: Visaka continues to give a good set of numbers. YoY EPS grew at 142% aided by a revenue growth of 1.5%

More information

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector 1QFY218 Result Update Banking August 2, 217 Federal Bank Performance Highlights Particulars (` cr) 1QFY18 4QFY17 % chg (qoq) 1QFY17 % chg (yoy) NII 8.7 842.4 (5.) 692.7 15.6 Pre-prov. profit 557.9 549.2

More information

I Direct. nstinct. November 27, 2017

I Direct. nstinct. November 27, 2017 I Direct nstinct November 27, 2017 I-direct Instinct Key risks to investing in I-direct Instinct It is a quick pitch note, which captures the essence of an idea in brief Instinct idea may be based on management

More information

RBL Bank Ltd. Banking. ACCUMULATE Rating as per Mid Cap 12 months investment period RETAIL EQUITY RESEARCH

RBL Bank Ltd. Banking. ACCUMULATE Rating as per Mid Cap 12 months investment period RETAIL EQUITY RESEARCH Q1FY18 RESUL UPDATE Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 RETAIL EQUITY RESEARCH RBL Bank Ltd. Banking BSE CODE: 540065 NSE CODE: RBLBANK Bloomberg CODE: RBK:IN SENSEX:

More information

Key estimate revision. Financial summary. Year

Key estimate revision. Financial summary. Year : price: ABV: How does our one year outlook change? Retain our positive view on the stock. We continue to believe that SUF is a multi-year compounding opportunity in the asset and home financing segments.

More information

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E Company Update Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E EBITDA Margins recovered by 618 bps QoQ: The company has witnessed many challenges over the year FY17 starting

More information

Manappuram Finance (MGFL IN) Healthy operating performance

Manappuram Finance (MGFL IN) Healthy operating performance INSTITUTIONAL EQUITY RESEARCH Manappuram Finance (MGFL IN) Healthy operating performance INDIA BFSI Quarterly Update Top takeaways from Q2FY19 Operating results ahead of expectations with NII/PAT at Rs

More information

Cummins India Ltd Bloomberg Code: KKC IN

Cummins India Ltd Bloomberg Code: KKC IN Company Update Margins Under Pressure; Domestic Recovery Underway Half-yearly revenue was flat; margins were under pressure: Cummins India revenue, EBITDA and PAT for H1FY17 reached to Rs.24,784mn, Rs.4,649mn

More information

Bajaj Finance Limited (BFL) NBFC. BUY Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

Bajaj Finance Limited (BFL) NBFC. BUY Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH COMPANY UPDATE Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 RETAIL EQUITY RESEARCH Bajaj Finance Limited (BFL) NBFC BSE CODE: 500034 NSE CODE: BAJFINANCE Bloomberg

More information

IDFC + Shriram Group. Deal not value accretive. Financial summary (FY17) 17 JUL 2017 Company Report Not Rated. Target Price: NA

IDFC + Shriram Group. Deal not value accretive. Financial summary (FY17) 17 JUL 2017 Company Report Not Rated. Target Price: NA Not Rated Target Price: NA CMP Potential Upside : Rs 65 : NA + Shriram Group Deal not value accretive MARKET DATA No. of Shares Market Cap Free Float Avg. daily vol (6mth) 52-w High / Low Bloomberg Promoter

More information

FY17 FY18 FY19E FY20E

FY17 FY18 FY19E FY20E 102015 012016 02016 072016 102016 012017 02017 072017 102017 01201 0201 07201 Result Update October 16, 201 IndusInd Bank Result Update Robust growth in advances Advances grew 32. YoY to 163,1cr on the

More information

Axis Bank Ltd. For private circulation only. Volume No.. III Issue No October 08, 2018

Axis Bank Ltd. For private circulation only. Volume No.. III Issue No October 08, 2018 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Volume No.. III Issue No. 188. Axis Bank Ltd. October 08, 2018 BSE Code: 532215 NSE Code: AXISBANK Reuters Code:

More information

Federal Bank Ltd. Banking/Finance. Accumulate RETAIL EQUITY RESEARCH

Federal Bank Ltd. Banking/Finance. Accumulate RETAIL EQUITY RESEARCH Q1FY19 RESULT UPDATE RETAIL EQUITY RESEARCH Federal Bank Ltd. Banking/Finance BSE CODE:500469 NSE CODE: FEDERALBNK Bloomberg CODE: FB IN SENSEX: 36,519 Accumulate Rating as per Midcap 12months investment

More information

Reduce. Punjab National Bank Banking RETAIL EQUITY RESEARCH. Not out of the woods. GEOJIT BNP PARIBAS Research. 10 th August 2016 Q1FY17 RESULT UPDATE

Reduce. Punjab National Bank Banking RETAIL EQUITY RESEARCH. Not out of the woods. GEOJIT BNP PARIBAS Research. 10 th August 2016 Q1FY17 RESULT UPDATE Q1FY17 RESULT UPDATE Aug-15 Sep-15 Oct-15 GEOJIT BNP PARIBAS Research Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 RETAIL EQUITY RESEARCH Punjab National Bank Banking BSE CODE:

More information

BUY RETAIL EQUITY RESEARCH. HDFC Ltd. NBFC. Better placed among housing finance companies (HFCs) GEOJIT BNP PARIBAS Research

BUY RETAIL EQUITY RESEARCH. HDFC Ltd. NBFC. Better placed among housing finance companies (HFCs) GEOJIT BNP PARIBAS Research Jan-16 Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Company Update GEOJIT BNP PARIBAS Research RETAIL EQUITY RESEARCH HDFC Ltd. NBFC BSE CODE: 500010 NSE CODE: HDFC

More information

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 Jul-18 Oct-18 Jan-19 Q3FY2019 Result Update Banking Feb 15, 2019 ICICI Bank Performance Highlights Particulars (` cr) Q3FY19 Q2FY19 % chg

More information

HDFC Bank Banking. BUY Rating as per Large Ccap 12 month investment period RETAIL EQUITY RESEARCH

HDFC Bank Banking. BUY Rating as per Large Ccap 12 month investment period RETAIL EQUITY RESEARCH Q1FY19 RESULT UPDATE Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 RETAIL EQUITY RESEARCH HDFC Bank Banking BSE CODE: 500180 NSE CODE: HDFCBANK Bloomberg CODE:

More information

BUY CIPLA INDIA. Steady growth, margin visibility amid headwinds. Target Price: Rs 675. Key drivers

BUY CIPLA INDIA. Steady growth, margin visibility amid headwinds. Target Price: Rs 675. Key drivers 13 NOV 2017 Quarterly Update BUY Target Price: Rs 675 Steady growth, margin visibility amid headwinds Cipla s Q2 EBITDA margin improved 156 bps YoY at 19.7% (despite 270 bps YoY decline in gross margin)

More information

Indostar Capital Finance

Indostar Capital Finance January 2, 2019 Buy Indostar Capital Finance Industry: BFSI Fallen, but not beaten down!!! We recently interacted with the management to get an understanding of the recent developments of the company post

More information

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS. Jan-14 Mar-14 Apr-14 May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 India Research Infrastructure April 10, 2015 EVENT UPDATE Bloomberg: IN Reuters: HCNS.BO BUY QIP step in the right direction has successfully

More information

Capital First. Continuing to grow strong. Source: Company Data; PL Research

Capital First. Continuing to grow strong. Source: Company Data; PL Research Continuing to grow strong May 07, 2018 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Shweta Daptardar shwetadaptardar@plindia.com / +91 22

More information

Bajaj Finserv (BAFINS) 4375

Bajaj Finserv (BAFINS) 4375 Company Update Rating matrix Rating Buy Target 4900 Target Period 12 months Potential Upside 12% What s Changed? Target Changed from 3620 to 4900 EPS FY17E Changed from 146.2 to 150.3 EPS FY18E Changed

More information

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23, : price: EPS: How does our one year outlook change? We retain our negative stance on the stock. We expect s revenue to de-grow by 9% y-o-y on the back of muted execution (client side and clearance delays)

More information

Manappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability

Manappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability INSTITUTIONAL EQUITY RESEARCH Manappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability INDIA BFSI Quarterly Update Top takeaways from Q1FY19 Operating results inline

More information

Bajaj Finserv (BAFINS) 3130

Bajaj Finserv (BAFINS) 3130 Company Update Rating matrix Rating Buy Target 3470 Target Period 12 months Potential Upside 11% What s Changed? Target Changed from 2900 to 3470 EPS FY17E EPS FY18E EPS FY19E Introducing at 242.3 Rating

More information

Bank of Baroda (BOB) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

Bank of Baroda (BOB) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH Q2FY18 RESULT UPDATE Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 RETAIL EQUITY RESEARCH Bank of Baroda (BOB) Banking BSE CODE: 532134 NSE CODE: BANKBARODA

More information

Ahluwalia Contracts (India)

Ahluwalia Contracts (India) May-14 Jul-14 Aug-14 Sep-14 Oct-14 Dec-14 Jan-15 Feb-15 Apr-15 May-15 India Research Infrastructure May 22, 215 QUARTERLY REVIEW Bloomberg: AHLU IN Reuters: AHLU.BO BUY Better performance ahead ACIL posted

More information

HDFC Bank (HDFCB IN) Continue to perform strong

HDFC Bank (HDFCB IN) Continue to perform strong INSTITUTIONAL EQUITY RESEARCH HDFC Bank (HDFCB IN) Continue to perform strong INDIA FINANCIALS Quarterly Update Top takeaways from Q3FY19 Earnings were in line with estimate. NII growth at 22% (vs expectation

More information

LIC Housing Finance. Source: Company Data; PL Research

LIC Housing Finance. Source: Company Data; PL Research High prepayment remains a drag; earnings momentum to sustain April 20, 2016 Nitin Kumar nitinkumar@plindia.com / +91 22 66322236 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 Vidhi Shah vidhishah@plindia.com

More information

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018 4QFY18 Result Update Institutional Equities South Indian Bank 15 May 2018 Reuters: SIBK.BO; Bloomberg: SIB IN Asset Quality Pain To Ease Hereafter South Indian Bank (SBL) reported 4QFY18 results with the

More information

Reliance Capital (RELCAP) 549

Reliance Capital (RELCAP) 549 Company Update Rating matrix Rating Buy Target 718 Target Period 12 months Potential Upside 31% Key Financials crore FY16E FY17E FY18E FY19E Revenues 9998 16776 18727 21501 PBT 1733 1459 1974 2560 Adjusted

More information